Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
SPC3042 is an antisense oligonuecliotide that targets Survivin leading to decreased Survivin expression, which may result in increased tumor cell apoptosis and increased sensitivity to chemotherapeutics (PMID: 18790754).
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Paclitaxel + SPC3042||Paclitaxel SPC3042||1||0|